Lexeo shares gain 5.4% after up to $21.3 million Mantle deal

Verifying
  • Lexeo agreed to acquire Mantle Therapeutics and announced three FA research collaborations.
  • Up to $21.3 million will fund the transaction, including $8.3 million upfront.
  • Lexeo expects the Mantle transaction to close in the third quarter of 2026.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.
Lexeo shares gain 5.4% after up to $21.3 million Mantle deal - CoinPost Terminal